ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

Exclusive-US Postpones Third Consecutive Meeting Of Preventive Health Panel

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

Spain Informs WHO of Possible Human Swine Flu Case

Spain has informed the World Health Organization of a possible infection with the swine flu virus that may have been transmitted between humans, a health official said on Friday.

Bird Flu Devastates 7.4 Million Pennsylvania Chickens in a Month

Bird flu has wiped out 7.4 million chickens in Pennsylvania in the past month, a swift and devastating loss that veterinarians and industry members suspect ⁠may be linked to...

CDC Acting Director Bhattacharya Urges Use of Measles Vaccine

The U.S. Centers for Disease Control and Prevention's new acting director, Jay Bhattacharya, on Monday urged Americans to get vaccinated against ⁠measles, saying it was the...

Longevity Research Is a Public Health Imperative: Barzilai

From healthcare costs to cancer survival and even space travel, Nir Barzilai explains why targeting aging is crucial for our entire society.

Africa CDC Cites Concerns Over Data Sharing in US Health Deals

There are big issues in health funding deals the US is pursuing with African countries, the head of the African CDC said Thursday.

Todays Updates

Should Biology Replace Organ Labels in Cancer Treatment?

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Saline Lavage Shows No Clinical Benefit in Pleural Infection

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Your Patient Doesn’t Like Your Accent or Color: Now What?

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Todays Updates

Should Biology Replace Organ Labels in Cancer Treatment?

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

US CDC Deploys Staff to Curb South Carolina's Measles Outbreak

(Refiles to remove extraneous word years from first paragraph)

After FDA Declined Review, EMA Backs 1st Flu-COVID mRNA Vax

The Moderna vaccine will likely be available in Europe long before the US.

Saline Lavage Shows No Clinical Benefit in Pleural Infection

Saline lavage, alone or combined with intrapleural enzyme therapy, confers no clinically meaningful advantage over intrapleural enzyme therapy alone in patients with pleural infection.

Your Patient Doesn’t Like Your Accent or Color: Now What?

Many doctors facing racism from patients stay silent, doubting they’ll be heard. Experts share strategies for handling bias when institutions fall short.

Doravirine Plus Islatravir Matches Standard HIV Therapy

In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus islatravir shows efficacy and safety similar to standard ART regimens.

Peak Anti-HBs Level May Predict Protection in HIV Infection

Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.

Latest News

The March meeting of the U.S. advisory panel that determines what cancer screenings and other preventive health measures insurers must cover has been postponed, according to...

Spain has informed the World Health Organization of a possible infection with the swine flu virus that may have been transmitted between humans, a health official said on Friday.

Bird flu has wiped out 7.4 million chickens in Pennsylvania in the past month, a swift and devastating loss that veterinarians and industry members suspect ⁠may be linked to...

The U.S. Centers for Disease Control and Prevention's new acting director, Jay Bhattacharya, on Monday urged Americans to get vaccinated against ⁠measles, saying it was the...

From healthcare costs to cancer survival and even space travel, Nir Barzilai explains why targeting aging is crucial for our entire society.

There are big issues in health funding deals the US is pursuing with African countries, the head of the African CDC said Thursday.

News All Time

RSV Vaccine in Multidose Vial Matches Single-Dose Vial

In healthy, nonpregnant women, the multidose vial of RSVpreF vaccine produces immune responses and safety outcomes comparable to the single-dose vial, a trial finds.

US FDA Reverses Course, Will Review Moderna's Flu Vaccine Application

Moderna said on Wednesday the U.S. Food and Drug Administration changed course and will review an amended application for its new flu vaccine, a week after rejecting the...

AAP Finds No New Evidence Against Hep B Vaccine Birth Dose

AAP publishes review of safety and efficacy of hepatitis B vaccination birth dose.

Healthy Life Expectancy Declines Again

Years spent in good health have dropped to their lowest level since comparable data were first collected in 2011 to 2013, with stark regional gaps across the UK.

Next-Day HIV Test Result Show Mixed Effects on Seeking Care

Next-day HIV viral load test results do not improve overall linkage to care when added to standard testing but are tied to faster linkage to antiretroviral therapy among people with HIV infection.

Long-Acting HIV Therapy May Be Safe After HBV Exposure

Switching to a long-acting cabotegravir/rilpivirine antiretroviral regimen may be safe for patients with HIV who have prior hepatitis B virus exposure, a real-world study shows.

Cancer Screening Gaps Leave People With HIV at Elevated Risk

International guidelines recommend anal and liver surveillance for people with HIV, but Brazil lacks a national protocol; clinicians should integrate screening and vaccination.

ED Screening Uncovers Elevated Risk for Cervical Cancer

Emergency department-based cervical cancer interventions identify precancerous lesions and high-risk human papillomavirus at rates higher than the national average, a study shows.

Pritelivir Shows Promise for HSV

The new oral therapy demonstrates superior lesion healing for complex patients who have few current treatment options.

STI Prevention With Doxycycline Raises Resistance Fears

Public health authorities warn clinicians to weigh risks and enroll patients in supervised programs: routine testing, partner management, and resistance surveillance are essential.

Gaps in Primary Care Affect Transgender Health in Spain

Data from more than 1800 participants outlines structural barriers, high mental health diagnoses, and uneven access to gender-affirming and preventive services.

AAS Misuse Damages Heart, Liver, Kidneys, and Brain

Supraphysiologic anabolic steroid use is increasing among recreational athletes, causing cardiac, psychiatric, renal, and reproductive complications.

Use of Opioid Combinations Tied to Impaired Cognition in HIV

The use of opioids alone does not significantly impair cognition in patients with HIV infection, but the combined use of opioids and antidepressants is linked to poorer neurocognitive performance.

Four States and New York City Join WHO Outbreak Network

After United States’ withdrawal from the WHO, four states and New York City have partnered with the WHO to maintain access to international outbreak intelligence and strengthen preparedness efforts.

Zimbabwe Rolls Out New HIV Prevention Drug Lenacapavir

Zimbabwe's health authorities begin administering the long-acting HIV prevention drug lenacapavir, making ⁠the country one of the first globally to roll it out.

Medicaid expansion increases access to HIV prevention medication for high-risk populations

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis who were prescribed preexposure prophylaxis (PrEP), a preventative medication taken in pill or injectable ...

Recommended News For You

Microplastics can cause malignant changes in lung cells

Study shows virtual reality headsets may help ease cancer pain

New imaging solution could help improve survival for patients with recurring prostate cancer

Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

Pancreatic cancer RNA vaccine shows durable T cell immunity

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

Recommended Articles For You

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care 

Angina Haemorrhagica Bullosa: What You Need to Know 

A Closer Look at MCV Modules: Features, Functions, and Benefits  

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

2.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

3.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

4.

In CML Patients With New Diagnoses, STAMP Inhibitor Outperforms Imatinib and Second-Gen TKIs.

5.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

1.

Malignant Prolactinoma: Prolactin Surge with Minimal Growth Masks Widespread Metastases

2.

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology

3.

Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management

4.

Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment

5.

Angina Haemorrhagica Bullosa: What You Need to Know

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

4.

Navigating the Complexities of Ph Negative ALL - Part V

5.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot